$VNRX
VolitionRx Limited
XASE•Health Care•In Vitro & in Vivo Diagnostic Substances
$0.189
▲After hours+0.00%+$0.000After hours
VolitionRx Limited
XASE•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is VNRX down today? It is at $0.189 (-6.94%), and our scanner flagged it 29 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VNRX spikes, and full due diligence on VNRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VNRX 29 times in the last 30 days. Create a free account to track $VNRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VNRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VNRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash, from the latest SEC filing. Read it →Across every filing on file, supply equal to 1361.6% of the tradeable float is in play - 1361.6% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,440,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $1.55/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Batchelor Ann-Louise Officer | Acquired (grant/award) | +12K 0.09% of company | added 76% | 28K | n/a | Oct 21, 26 |
Michel Gaetan Officer | Sold (automatic/other) | -608 | sold 4.7% | 12K | $152 at $0.250 | Sep 28, 26 |
Forterre Gael Officer | Sold (automatic/other) | -284 | sold 1.7% | 16K | $71 at $0.250 | Sep 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on VNRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VNRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VNRX last traded at $0.189, down 6.94% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
VolitionRx Limited (VNRX) is next expected to report earnings on Thursday, November 12, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VNRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VNRX 29 times in the last 30 days.
VNRX (VolitionRx Limited) trades on XASE, with a market cap of about $3M in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VNRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VNRX discussion
Sign in to ask a question or join the discussion.